Skip to content
Search

Latest Stories

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

Emergency Hormonal Contraception will be added to the Pharmacy Contraception Service as part of the newly agreed Community Pharmacy Contractual Framework (CPCF) for 2025/26.

Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.


The investment aims to expand pharmacy services, shifting more care from hospitals into the community to improve patient access and reduce GP pressures.

From October 2025, Emergency Hormonal Contraception (EHC) will be added to the Pharmacy Contraception Service (PCS).

In a letter to community pharmacy contractors, the department emphasised that this expansion will “allow all community pharmacies across England to maximise the service’s benefits by initiating a patient on oral contraception as part of an EC consultation and claim payment for both services.”

The fee for an EC consultation will be £20.

Additionally, under the PCS, the fee for both initiation and continuation consultations will increase from £18 to £25.

Additionally, the government has agreed to allow pharmacy technicians to deliver Patient Group Directions (PGDs), enabling the supply of drospirenone for contraception.

Nick Kaye, chair of the National Pharmacy Association (NPA), welcomed the announcement, stating: "We've long called for national commissioning of emergency contraception so this is good news for patients and pharmacies alike.”

"For too long, access to free services has been a postcode lottery for patients, with local arrangements only existing in certain parts of the country and often being underfunded.

"Pharmacies are under enormous pressure amid the impact of record cuts to their budgets, so it is important any scheme fully reimburses them for this work."

The Royal Pharmaceutical Society (RPS), which has long advocated for the provision of free emergency contraception through community pharmacies in England to align with counterparts in Scotland and Wales, is pleased this will now become a reality.

"Reducing disparities in access will lead to better health outcomes, empower women with greater choice and help reduce health inequalities," saidTase Oputu, chair of RPS England.

All pharmacists and registered pharmacy professionals providing emergency contraception will be required to complete CPPE Emergency Contraception training.

Health Minister Stephen Kinnock reiterated that community pharmacists are “at the heart of local healthcare” and emphasised the government's commitment to expanding their role as part of the Plan for Change, shifting care from hospitals into the community.

“This package of record investment and reform is a vital first step to getting community pharmacies back on their feet and fit for the future.

“The agreement shows how this government is working in partnership with community pharmacy to deliver more care for patients closer to their home, freeing up GP appointments, and catching ill-health earlier and preventing it in the first place,” he said.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less